|
⚲
|
| Keyboard |
| Hecht Beth
✚
|
|
|---|---|
| CIK # | 0001652410 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001652410] | |
| 4 | [0001652410] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Xeris Biopharma Holdings Inc | |
| Hecht Beth | |
| Iterum Therapeutics Ltd | |
| Xeris Pharmaceuticals Inc | |
| Aytu Biopharma Inc | |
| Neos Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Xeris Biopharma Holdings Inc XERS
Common Stock
|
2026-03-02 | Sell | 16,567 | $6.24 | 103,378 |
|
Xeris Biopharma Holdings Inc XERS
Common Stock
|
2026-03-02 | Sell | 100 | $7.06 | 706 |
|
Xeris Biopharma Holdings Inc XERS
Common Stock
|
2026-02-02 | Sell | 16,667 | $7.45 | 124,169 |
|
Xeris Biopharma Holdings Inc XERS
Common Stock
|
2026-01-31 | Tax withheld | 24,266 | $7.36 | 178,598 |
|
Xeris Biopharma Holdings Inc XERS
Common Stock
|
2026-01-31 | Tax withheld | 46,914 | $7.36 | 345,287 |
|
Xeris Biopharma Holdings Inc XERS
Common Stock
|
2026-01-31 | Tax withheld | 98,375 | $7.36 | 724,040 |
|
Xeris Biopharma Holdings Inc XERS
Stock Option (Right to Buy) · derivative
|
2026-01-30 | Grant | 162,162 | $0.00 | |
|
Xeris Biopharma Holdings Inc XERS
Common Stock
|
2026-01-30 | Grant | 121,293 | $0.00 | |
|
Xeris Biopharma Holdings Inc XERS
Common Stock
|
2026-01-02 | Sell | 16,667 | $7.43 | 123,836 |
|
Xeris Biopharma Holdings Inc XERS
Common Stock
|
2025-12-01 | Sell | 16,667 | $7.01 | 116,836 |
|
Xeris Biopharma Holdings Inc XERS
Common Stock
|
2025-11-11 | Sell | 16,667 | $7.40 | 123,336 |
|
Xeris Biopharma Holdings Inc XERS
Common Stock
|
2025-03-20 | Sell | 40,000 | $5.43 | 217,200 |
|
Xeris Biopharma Holdings Inc XERS
Common Stock
|
2025-01-31 | Tax withheld | 45,909 | $3.56 | 163,436 |
|
Xeris Biopharma Holdings Inc XERS
Common Stock
|
2025-01-31 | Grant | 185,000 | $0.00 | |
|
Xeris Biopharma Holdings Inc XERS
Common Stock
|
2025-01-31 | Tax withheld | 98,375 | $3.56 | 350,215 |
|
Xeris Biopharma Holdings Inc XERS
Stock Appreciation Right · derivative
|
2025-01-31 | Grant | 300,000 | $0.00 | |
|
Xeris Biopharma Holdings Inc XERS
Common Stock
|
2025-01-03 | Tax withheld | 32,039 | $3.61 | 115,661 |
|
Xeris Biopharma Holdings Inc XERS
Common Stock
|
2024-01-31 | Grant | 750,000 | $0.00 | |
|
Xeris Biopharma Holdings Inc XERS
Common Stock
|
2024-01-31 | Tax withheld | 45,909 | $2.46 | 112,936 |
|
Xeris Biopharma Holdings Inc XERS
Common Stock
|
2024-01-29 | Tax withheld | 19,675 | $2.66 | 52,336 |
| showing 20 of 74 most recent transactions | |||||